Trials / Terminated
TerminatedNCT03914495
The Role of Microbiome Reprogramming on Liver Fat Accumulation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate whether reprogramming the microbiome via soluble fiber supplementation will decrease liver fat in obese individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Inulin | Powdered inulin will be provided in pre-weighed portions for consumption in a 1 week titration to reduce GI side effects with a 21 day intervention at full dose. |
| DIETARY_SUPPLEMENT | Placebo | Powdered maltodextrin will be provided in pre-weighed portions for consumption in a 1 week titration with a 21 day intervention at full dose. |
Timeline
- Start date
- 2019-05-21
- Primary completion
- 2021-06-02
- Completion
- 2021-06-09
- First posted
- 2019-04-16
- Last updated
- 2023-02-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03914495. Inclusion in this directory is not an endorsement.